Content about Amyotrophic lateral sclerosis

November 14, 2013

Domestic violence has devastating effects on families, but new research also links it to chronic disease in women and calls on healthcare professionals to do more to determine whether there may be a link between the two in patients.

WASHINGTON — Domestic violence has devastating effects on families, but new research also links it to chronic disease in women and calls on healthcare professionals to do more to determine whether there may be a link between the two in patients.

October 31, 2013

Earlier this year, the Food and Drug Administration approved a new drug for treating cystic fibrosis for patients who have a specific genetic mutation, but that also treats the underlying cause of the disease rather than the disease itself.

SILVER SPRINGS, Md. — Earlier this year, the Food and Drug Administration approved a new drug for treating cystic fibrosis for patients who have a specific genetic mutation, but that also treats the underlying cause of the disease rather than the disease itself.

July 31, 2013

Nearly 450 drugs are under development for treating neurological disorders, according to a report by a drug industry trade group.

WASHINGTON — Nearly 450 drugs are under development for treating neurological disorders, according to a report by a drug industry trade group.

The Pharmaceutical Research and Manufacturers of America said in a report released Wednesday that drug makers had 444 drugs in clinical development or awaiting Food and Drug Administration approval for a range of diseases, ranging from mild to serious.

June 11, 2013

Aceto Corp. will sell an authorized generic version of a drug used to treat a rare but devastating degenerative disorder.

PORT WASHINGTON, N.Y. — Aceto Corp. will sell an authorized generic version of a drug used to treat a rare but devastating degenerative disorder.

Aceto said it would launch the authorized generic version of Covis Pharma's Rilutek (riluzole) tablets in the 50-mg strength through its Rising Pharmaceuticals subsidiary. The drug is used to treat amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

Sales of the drug were about $64 million in 2012, according to Aceto.

 

June 3, 2013

CVS/pharmacy has announced the launch of its annual in-store Advancing Medical Research fundraising campaign to support medical research and help improve the quality of life for those living with amyotrophic lateral sclerosis (ALS).

WOONSOCKET, R.I. — CVS/pharmacy has announced the launch of its annual in-store Advancing Medical Research fundraising campaign to support medical research and help improve the quality of life for those living with amyotrophic lateral sclerosis (ALS).

May 10, 2013

A biotech company and a non-profit organization are looking into new ways to treat patients with the devastating degenerative disorder commonly known as Lou Gehrig's disease.

SAN DIEGO — A biotech company and a nonprofit organization are looking into new ways to treat patients with the devastating degenerative disorder commonly known as Lou Gehrig's disease.

The ALS Emergency Treatment Fund and Denovo Biomarkers announced Friday a deal to explore the use of personalized medicine in treating patients with the disease, known medically as amyotrophic lateral sclerosis. The two said the approach could accelerate drug development in ALS and other life-threatening disorders.

January 3, 2013

An experimental drug for Lou Gehrig's disease made by Biogen Idec has failed in a late-stage clinical trial, the drug maker said.

WESTON, Mass. — An experimental drug for Lou Gehrig's disease made by Biogen Idec has failed in a late-stage clinical trial, the drug maker said Thursday.

Biogen announced results of its phase-3 trial of dexpramipexole in patients with the disease, known technically as amyotrophic lateral sclerosis, or ALS. The drug failed to improve functioning and survival in patients and failed to show efficacy in key secondary endpoints as well, the company said.

November 19, 2012

Drug maker Shire has started a research program focused on rare diseases and their effects on patients and healthcare professionals, the company said Monday.

LEXINGTON, Mass. — Drug maker Shire has started a research program focused on rare diseases and their effects on patients and healthcare professionals, the company said Monday.

Shire announced the launch of the Shire Rare Disease Impact Report, which includes surveys of patients, caregivers, physicians, payers and others in the United States and United Kingdom, with results expected in the first half of 2013.

September 10, 2012

Amyotrophic lateral sclerosis patients from Chagrin Falls, Ohio, and cystic fibrosis patients from Indianapolis took part in pre-game, on-field traditions at Fenway Park to celebration CVS/pharmacy's Advancing Medical Research fundraising campaign, which raised more than $5 million in five weeks.

WOONSOCKET, R.I. — Amyotrophic lateral sclerosis patients from Chagrin Falls, Ohio, and cystic fibrosis patients from Indianapolis took part in pre-game, on-field traditions at Fenway Park to celebration CVS/pharmacy's Advancing Medical Research fundraising campaign, which raised more than $5 million in five weeks.

August 29, 2012

In the battle to find a cure for amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, scientists from Belgium have made a rare discovery: a new gene that influences survival time of ALS. The findings, reported in a recent issue of Nature Medicine, were funded in part by CVS/pharmacy and the ALS Therapy Alliance, a Boston-based nonprofit.

NEEDHAM, Mass. — In the battle to find a cure for amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, scientists from Belgium have made a rare discovery: a new gene that influences survival time of ALS. The findings, reported in a recent issue of Nature Medicine, were funded in part by CVS/pharmacy and the ALS Therapy Alliance, a Boston-based nonprofit. The findings also confirm another recent study that identified the same pathway to finding a treatment for ALS.

August 3, 2012

A drug made by Pfizer and used to treat overactive bladder was effective in reducing leakage of urine in patients with the disorder, according to the results of a post-approval clinical study.

NEW YORK — A drug made by Pfizer and used to treat overactive bladder was effective in reducing leakage of urine in patients with the disorder, according to the results of a post-approval clinical study.

Pfizer announced Friday results of a phase-4 study of Toviaz (fesoterodine fumarate) in the reduction of urge urinary incontinence in patients with OAB who had a less than 50% reduction in UUI when taking Detrol LA (tolterodine tartrate), a commonly prescribed treatment for the condition also made by Pfizer.

May 29, 2012

CVS/pharmacy has announced the launch of a new in-store fundraising campaign, named Advancing Medical Research, to support medical research and help improve the quality of life for those living with amyotrophic lateral sclerosis and cystic fibrosis.

WOONSOCKET, R.I. — CVS/pharmacy has announced the launch of a new in-store fundraising campaign, named Advancing Medical Research, to support medical research and help improve the quality of life for those living with amyotrophic lateral sclerosis and cystic fibrosis.
 
Funds raised through the campaign will benefit the ALS Therapy Alliance, an organization dedicated to advancing ALS research, and the Cystic Fibrosis Foundation. Supporters for the 2012 campaign can donate $1 or $3 at the register in CVS/pharmacy locations and online through June 30.

February 15, 2012

The Food and Drug Administration will review a regulatory approval application from Pfizer for a drug to treat an extremely rare and fatal degenerative disease, Pfizer said Wednesday.

NEW YORK — The Food and Drug Administration will review a regulatory approval application from Pfizer for a drug to treat an extremely rare and fatal degenerative disease, Pfizer said Wednesday.

Pfizer announced that the FDA had accepted its application for tafamidis meglumine, a treatment for transthyretin familial amyloid polyneuropathy. The disease, also known as TTR-FAP, is a fatal genetic illness that affects about 8,000 people worldwide and causes severe sensory loss, pain, weakness and organ dysfunction.

October 11, 2011

A CVS Caremark-sponsored study looking at in-person, electronic, telephone, fax and mail communications that counsel patients to stay on their medications found that pharmacists in a retail setting are the most influential healthcare “voices” in promoting medication adherence.


A CVS Caremark-sponsored study looking at in-person, electronic, telephone, fax and mail communications that counsel patients to stay on their medications found that pharmacists in a retail setting are the most influential healthcare “voices” in promoting medication adherence.


September 1, 2011

Country music star Ty Herndon and former NFL player Kevin Turner joined amyotrophic lateral sclerosis patients Thursday evening at Fenway Park to celebrate the success of CVS/pharmacy’s annual in-store fundraising campaign to support the fight against ALS.

WOONSOCKET, R.I. — Country music star Ty Herndon and former NFL player Kevin Turner will join amyotrophic lateral sclerosis patients Thursday evening at Fenway Park to celebrate the success of CVS/pharmacy’s annual in-store fundraising campaign to support the fight against ALS.

The $4.3 million generated by this year's campaign brings the total amount raised by CVS/pharmacy colleagues and customers for ALS research to more than $27 million.

June 8, 2011

The Food and Drug Administration has granted orphan drug designation to an investigational treatment made by Edison Pharmaceuticals for rare diseases, Edison said Wednesday.

MOUNTAIN VIEW, Calif. — The Food and Drug Administration has granted orphan drug designation to an investigational treatment made by Edison Pharmaceuticals for rare diseases, Edison said Wednesday.

June 6, 2011

CVS/pharmacy kicked off on June 5 its 10th annual in-store "Researching a Cure" fundraising campaign to support the fight against amyotrophic lateral sclerosis.

WOONSOCKET, R.I. — CVS/pharmacy kicked off on June 5 its 10th annual in-store "Researching a Cure" fundraising campaign to support the fight against amyotrophic lateral sclerosis.

Funds raised through the campaign benefit the ALS Therapy Alliance, an organization dedicated to advancing ALS research. Through the Researching a Cure campaign, CVS/pharmacy has raised more than $23 million in its stores and online to fund new clinical research with the aim of discovering a treatment or cure for ALS. The 2011 campaign will run through June 25.

May 26, 2011

Medication nonadherence is sort of similar to substance abuse: It’s a societal issue that stems from multiple causes and as such, probably will never completely disappear; however, it still can be mitigated. And because it stems from multiple causes, effectively combating it also requires multiple strategies.

WHAT IT MEANS AND WHY IT'S IMPORTANT — Medication nonadherence is sort of similar to substance abuse: It’s a societal issue that stems from multiple causes and as such, probably will never completely disappear; however, it still can be mitigated. And because it stems from multiple causes, effectively combating it also requires multiple strategies.

May 25, 2011

Many people who provide care and support to loved ones said they are more likely to be nonadherent to their own personal medication regimen than to neglect providing medications to those they are caring for, according to a new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark.

WOONSOCKET, R.I. — Many people who provide care and support to loved ones said they are more likely to be nonadherent to their own personal medication regimen than to neglect providing medications to those they are caring for, according to a new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark. Given this, there's a significant opportunity for pharmacists and doctors to identify and work with caregivers to improve medication adherence and chronic disease management.

February 22, 2011

Specialty pharmacy provider BioScrip has launched a Web service designed to connect healthcare professionals, patients and caregivers in order to help patients manage their medications and improve their overall care experience.

ELMSFORD, N.Y. — Specialty pharmacy provider BioScrip has launched a Web service designed to connect healthcare professionals, patients and caregivers in order to help patients manage their medications and improve their overall care experience.

The website, myBioScrip.com, uses HealthyCircles, an online platform that enables people to use manage and share health information.

December 22, 2010

Pharmacists at a retail pharmacy are the most influential healthcare "voice" in getting patients to take their medications as prescribed, followed by nurses talking with patients as they are discharged from a hospital, according to research sponsored by CVS Caremark.

WOONSOCKET, R.I. — Pharmacists at a retail pharmacy are the most influential healthcare "voice" in getting patients to take their medications as prescribed, followed by nurses talking with patients as they are discharged from a hospital, according to research sponsored by CVS Caremark.

November 14, 2010

The drumbeat in support of an expanded universally recognized role for pharmacists in helping patients...

ALEXANDRIA, Va. — The drumbeat in support of an expanded universally recognized role for pharmacists in helping patients successfully manage their drug therapy is getting steadily louder.

September 30, 2010

CVS/pharmacy's ninth annual in-store Research a Cure fundraising campaign to support the fight against amyotrophic...

September 27, 2010

The Food and Drug Administration has approved a generic version of a drug for a...

MUMBAI, India The Food and Drug Administration has approved a generic version of a drug for a devastating muscular disorder.

 

Sun Pharmaceutical Industries announced Tuesday the approval of riluzole hydrochloride in the 50-mg strength. The tablets are used to treat amyotrophic lateral sclerosis or ALS, also known as Lou Gehrig’s disease.

 

 

The drug is a generic version of Sanofi-Aventis’ Rilutek, which has sales of around $50 million, according to Sun.

 

September 12, 2010

CVS/pharmacy recently celebrated its foray into the Omaha, Neb., market with a ribbon-cutting ceremony at...